Publication — IRIC MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. Date de publication 1st April 2018 Chercheur(euse)s Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M, Seshan V, Bhola P, O'Donnell C, Spitzer B, Stutzke C, Lavallée VP, Hébert J, Krivtsov AV, Melnick A, Paietta EM, Tallman MS, Letai A, Sauvageau G, Pouliot G, Levine R, Marto JA, Armstrong SA, Kentsis A Référence PubMed Cancer Discov 2018;8(4):478-497 ID PubMed 29431698 Affiliation Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.